Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 …
Orsi E; Solini A; Bonora E; Vitale M; Garofolo M; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Laviola L; Morano S; Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
Acta Diabetol
(Unknown)
Published: 2022
SARS-CoV-2 Omicron symptoms and adverse effects of GLP-1 RA therapy.
Acta Diabetol
(Unknown)
Published: 2022
The effect of zinc supplementation on glucose homeostasis: a randomised double-blind placebo-controlled trial.
Attia JR; Holliday E; Weaver N; Peel R; Fleming KC; Hure A; Wiggers J; McEvoy M; Searles A; Reeves P; Ranasinghe P; Jayawardena R; Samman S; Luu J; Rissel C; Acharya S.
Acta Diabetol
(Unknown)
Published: 2022
Urinary interleukin-9 in youth with type 1 diabetes mellitus.
Semenchuk J; Sullivan K; Moineddin R; Mahmud F; Dart A; Wicklow B; Xiao F; Medeiros T; Scholey J; Burger D.
Acta Diabetol
(Unknown)
Published: 2022
Italian guidelines for the treatment of type 2 diabetes.
Mannucci E; Candido R; Monache LD; Gallo M; Giaccari A; Masini ML; Mazzone A; Medea G; Pintaudi B; Targher G; Trento M; Turchetti G; Lorenzoni V; Monami M; for Società Italiana di Diabetologia (SID) and Associazione Medici Diabetologi (AMD).
Acta Diabetol
(Unknown)
Published: 2022
Pregnancy outcomes in women with type 1 diabetes using insulin degludec.
Acta Diabetol
(Unknown)
Published: 2022